Brief

Clinical and Vaccine Trials for Covid-19: Key Considerations from Social Science

Published on 8 October 2020

Previous months have witnessed a growth of clinical research in response to the Covid-19 crisis. This brief sets out social science considerations that can inform clinical and vaccine trials for Covid-19.

It was developed for SSHAP by London School of Hygiene and Tropical Medicine (LSHTM) by Rose Burns, Alex Bowmer, Luisa Enria, Samantha Vanderslott (University of Oxford) and Shelley Lees in order to inform design, recruitment and community engagement, implementation and results dissemination for trials of emerging vaccine and therapeutic candidates for Covid-19. Colleagues from Dalhousie University and Kings college London reviewed it.

Cite this publication

SSHAP (2020) Clinical and Vaccine Trials for COVID-19: Key Considerations from Social Science (October 2020), SSHAP

Authors

Rose Burns
Luisa Enria
Alex Bowmer
Samantha Vanderslott
Shelley Lees

Publication details

language
English

Share

About this publication

Related content

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.